Biobehavioral factors and cancer progression: Physiological pathways and mechanisms

Psychosomatic Medicine

Volumn 73, Issue 9, 2011, Pages 724-730

  Lutgendorf, Susan K ^a   Sood, Anil K ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

angiogenesis; biobehavioral; cancer; social support; stress

Indexed keywords

FOCAL ADHESION KINASE; GLUCOCORTICOID; INTERLEUKIN 6; INTERLEUKIN 8; ISOPRENALINE; MATRIX METALLOPROTEINASE; NORADRENALIN; STRESS HORMONE; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANOIKIS; AUTONOMIC DYSFUNCTION; BEHAVIOR; BIOBEHAVIORAL FACTOR; CANCER GROWTH; CANCER INVASION; CELL STRESS; CENTRAL NERVOUS SYSTEM; CLINICAL STUDY; DNA REPAIR; EXTRACELLULAR MATRIX; GENE EXPRESSION; HOST CELL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; METASTASIS; MOLECULAR INTERACTION; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; TUMOR CELL; TUMOR MICROENVIRONMENT;

EID: 80855143775     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e318235be76     Document Type: Review

References (109)

1. Brock AJ. Greek Medicine: Being Extracts Illustrative of Medical Writers From Hippocrates to Galen. London, England: JM Dent and Sons; 1929.
2. Bleiker EMA, van der Ploeg HM, Hendriks JHCL, Adèr HJ. Personality factors and breast cancer development: a prospective longitudinal study. J Natl Cancer Inst 2008;88:1478-82.
3. Cassileth BR. Stress and the development of breast cancer: a persistent and popular link despite contrary evidence. Cancer 1996;77:1015-6. (Pubitemid 26080887)
4. Duijts SFA, Zeegers MPA, Borne BV. The association between stressful life events and breast cancer risk: a meta-analysis. Int J Cancer 2003; 107:1023-9. (Pubitemid 37429846)
5. Penninx BW, Guralnik JM, Pahor M, Ferrucci L, Cerhan JR,Wallace RB, Havlik RJ. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 1998;90:1888-93. (Pubitemid 29014222)
6. Lillberg K, Verkasalo PK, Kaprio J, Teppo L, Helenius H, Koskenvuo M. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol 2003;157:415-23. (Pubitemid 36258597)
7. Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol 2007;25:2397-405. (Pubitemid 46999210)
8. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009;115:5349-61.
9. Giese-Davis J, Collie K, Rancourt KMS, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 2011;29:413-20.
10. Hamer M, Chida Y, Molloy GJ. Psychological distress and cancer mortality. J Psychosom Res 2009;66:255-8.
11. Palesh O, Butler LD, Koopman C, Giese-Davis J, Carlson R, Spiegel D. Stress history and breast cancer recurrence. J Psychosom Res 2007;63: 233-9. (Pubitemid 47268531)
12. Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 2006;24:1105-11. (Pubitemid 46646222)
13. Sprehn GC, Chambers JE, Saykin AJ, Konski A, Johnstone PA. Decreased cancer survival in individuals separated at time of diagnosis: critical period for cancer pathophysiology? Cancer 2009;115:5108-16.
14. Kravdal O. The impact of marital status on cancer survival. Soc Sci Med 2001;52:357-68.
15. Pinquart M, Duberstein PR. Depression and cancer mortality: a metaanalysis. Psychol Med 2010;40:1797-810.
16. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival Nat Clin Pract Oncol 2008;5:466-75.
17. Pinquart M, Duberstein PR. Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol 2010;75:122-37.
18. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269-82. (Pubitemid 37267857)
19. Petticrew M, Bell R, Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 2002;325:1066-76.
20. Antoni M, Lutgendorf S, Cole S, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M, Sood AK. The influence of biobehavioural factors on tumor biology: pathways and mechanisms. Nat Rev Cancer 2006;6: 240-8. (Pubitemid 43292567)
21. Levy S, Herberman R, Lee J, Whiteside T, Kirkwood J, McFeeley S. Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Nat Immun Cell Growth Regul 1990;9:313-24.
22. Levy S, Herberman R, Lippman M, D'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 1987;5:348-53. (Pubitemid 17045455)
23. Levy S, Herberman R, Lippman M, D'Angelo T, Lee J. Immunological and psychosocial predictors of disease recurrence in patients with earlystage breast cancer. Behav Med 1991;17:67-75.
24. Levy S, Herberman R, Maluish A, Schlein B, Lippman M. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 1985;4:99-113.
25. Levy SM. Behavioral and immunological host factors in cancer risk. In: McCabe PM, Schneiderman N, Field TM, Skyler JS, editors. Stress, Coping and Disease. Hillsdale, NJ: Lawrence Erlbaum Associates; 1991:237-53.
26. Glaser R, Thorn B, Tarr K, Kiecolt-Glaser J, D'Ambrosio S. Effects of stress on methyltransferase synthesis: an important DNA repair enzyme. Health Psychol 1985;4:403-12.
27. Kiecolt-Glaser JK, Stephens RE, Lipetz PD, Speicher CE, Glaser R. Distress and DNA repair in human lymphocytes. J Behav Med 1985; 8:311.
28. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-25. (Pubitemid 39303129)
29. Zorrilla EP, Luborsky L, McKay JR. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001;15:199-226. (Pubitemid 33070955)
30. Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun 2002;16:1-16. (Pubitemid 35439152)
31. Thornton LM, Andersen BL, Crespin TR, Carson WE. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav Immun 2007;21:185-94. (Pubitemid 46043587)
32. Varker KA, Terrell CE, Welt M. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobulin-like receptors. J Surg Res 2007;139:36-44. (Pubitemid 46482568)
33. Andersen B, Farrar WB, Golden-Kreutz D, Kutz LA, MacCallum R, Courtney ME, Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 1998;90:30-6. (Pubitemid 28078078)
34. Blomberg BB, Alvarez JP, Diaz A, Romero MG, Lechner SC, Carver CS, Holley H, Antoni MH. Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: an exploratory study. J Psychosom Res 2009;67:369-76.
35. Sephton SE, Dhabhar FS, Keuroghlian AS, Giese-Davis J, McEwen BS, Ionan AC, Spiegel D. Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain Behav Immun 2009;23: 1148-55.
36. Von AD, Kang D, Carpenter J. Stress, optimism, and social support: impact on immune responses in breast cancer. Res Nurs Health 2007;30: 72-83.
37. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 2002;3:999-1005. (Pubitemid 35363649)
38. Garcia-Lora A, Algarra I, Garrido F. MHC Class I antigens, immune surveillance, and tumor escape. J Cell Physiol 2003;195:346-55. (Pubitemid 36529863)
39. Lutgendorf S, Sood AK, Anderson B, McGinn S, Maiseri H, Dao M, Sorosky JI, De Geest K, Ritchie J, Lubaroff DM. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol 2005;23:7105-13.
40. Lutgendorf SK, Lamkin D, DeGeest K, Anderson B, Dao M, McGinn S, Zimmerman B, Maiseri H, Sood AK, Lubaroff DM. Depressed and anxious mood and T-cell cytokine producing populations in ovarian cancer patients. Brain Behav Immun 2008;22:890-900.
41. Andersen BA, Yang H-C, Farrar WB, Golden-Kreutz DM, Emery CF, Thornton LF, Young, DC, Carson WE. Psychologic intervention improves survival for breast cancer patients. Cancer 2008;113:3450-8.
42. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 2003;17:27-36.
43. Ben-Eliyahu S, Page GG, Yimira R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999;80:880-8. (Pubitemid 29108864)
44. Glasner A, Avraham R, Rosenne E, Benish M, Zmora O, Shemer S, Meiboom H, Ben-Eliyahu S. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 2010;184:2449-57.
45. Ben-Eliyahu S, Shakhar G, Page GG, Stefanski V, Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 2000;8:154-64. (Pubitemid 32008827)
46. Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, Ben-Eliyahu S. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 2008;15:2042-52.
47. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 2003;10:972-92. (Pubitemid 40486865)
48. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-8. (Pubitemid 37328849)
49. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6. (Pubitemid 20020880)
50. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7. (Pubitemid 17009577)
51. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.
52. SpannuthWA, Sood AK, Coleman RL. Angiogenesis as a strategic target for ovarian cancer therapy. Nat Clin Pract Oncol 2008;5:194-204. (Pubitemid 351493679)
53. Lutgendorf SK, Johnsen EL, Cooper B, Anderson B, Sorosky JI, Buller RE, Sood AK. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 2002;95:808-15. (Pubitemid 34839673)
54. Lutgendorf SK, Lamkin DM, Jennings NB, Arevalo JM, Penedo F, DeGeest K, Langley RR, Lucci JA 3rd, Cole SW, Lubaroff DM, Sood AK. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma. Clin Cancer Res 2008;14:6839-46.
55. Nausheen B, Carr NJ, Peveler RC, Moss-Morris R, Verrill C, Robbins E, Nugent KP, Baker AM, Judd M, Gidron Y. Relationship between loneliness and proangiogenic cytokines in newly diagnosed tumors of colon and rectum. Psychosom Med 2010;72:912-6.
56. Sharma A, Greenman J, Sharp DM, Walker LG, Monson JR. Vascular endothelial growth factor and psychosocial factors in colorectal cancer. Psychooncology 2008;17:66-73. (Pubitemid 351166279)
57. Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M, Sood AK. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 2003;9:4514-21. (Pubitemid 37248410)
58. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase MMP-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66:10357-64. (Pubitemid 44799755)
59. Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC,Webster Marketon JI, Barsky SH, Glaser R. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stressrelated enhancement of tumor progression. Brain Behav Immun 2009;23: 267-75.
60. Yang EV, Donovan EL, Benson DM, Glaser R. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun 2008;22:318-23. (Pubitemid 351172710)
61. Thaker P, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Chronic stress promotes tumor growth and metastasis in ovarian carcinoma. Nat Med 2006;12:939-44. (Pubitemid 44175146)
62. Lee J, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, Lokshin AE, Sood AK. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 2009;15: 2695-702.
63. Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK. Stress hormones regulate IL-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem 2007;282:29919-26. (Pubitemid 350035290)
64. Cohen T, Nahari D, Cerem LW, Neufield G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736-41. (Pubitemid 26034921)
65. Costanzo ES, Lutgendorf SK, Sood AK, Anderson B, Sorosky J, Lubaroff DM. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 2005;104:305-13. (Pubitemid 40993257)
66. Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L, Krueger G, Clevenger L, Lubaroff DM, Sood AK, Cole SW. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun 2011;25:250-5.
67. Hagemann T, Robinson SC, Schulz M, Trümper L, Balkwill FR, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004;25:1543-9. (Pubitemid 39162720)
68. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Stress hormone mediated invasion of ovarian cancer cells. Clin Cancer Res 2006;12:369-75. (Pubitemid 43166123)
69. Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrineinduced migration of SW 480 colon carcinoma cells is inhibited by betablockers. Cancer Res 2001;61:2866-9. (Pubitemid 32691927)
70. Drell TL, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 2003;80:63-70. (Pubitemid 36851285)
71. Yang E, Bane CM, MacCallum RC, Kiecolt-Glaser JK, Malarkey WB, Glaser R. Stress-related modulation of matrix metalloproteinase expression. J Neuroimmunol 2002;133:144-50. (Pubitemid 35346736)
72. Shanmugathasan M, Jothy S. Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 2000;50:273-9. (Pubitemid 30441278)
73. Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC, Imai K. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene 1998;16:2681-6. (Pubitemid 28264045)
74. Sood AK, Armaiz-Pena GN, Halder J, Nick AM, Stone RL, HuW, Carroll AR, Spannuth WA, Deavers MT, Allen JK, Han LY, Kamat AA, Shahzad MM, McIntyre BW, Diaz-Montero CM, Jennings NB, Lin YG, Merritt WM, DeGeest K, Vivas-Mejia PE, Lopez-Berestein G, Schaller MD, Cole SW, Lutgendorf SK. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest 2010;120: 1515-23.
75. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8. (Pubitemid 38082155)
76. Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett 2008;267:204-15.
77. Sica A, Rubino L, Mancino A, Larghi P, Porta C, Rimoldi M, Solinas G, Locati M, Allavena P, Mantovani A. Targeting tumour-associated macrophages. Expert Opin Ther Targets 2007;11:1219-29. (Pubitemid 47527326)
78. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour. Eur J Cancer 2006;42:717-27.
79. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-65. (Pubitemid 34189413)
80. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-7. (Pubitemid 40568680)
81. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005; 14:425-31.
82. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, Sood AK, Cole SW. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 2010;70:7042-52.
83. Hughes JW, Watkins L, Blumenthal JA, Kuhn C, Sherwood A. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J Psychosom Res 2004;57:353-8. (Pubitemid 39424247)
84. Lutgendorf SK, DeGeest K, Sung CY, Arevalo JMG, Penedo F, Lucci JA III, Goodheart M, Lubaroff D, Farley D, Sood AK, Cole SW. Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav Immun 2009;23:176-83.
85. Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 2000;6:703-6. (Pubitemid 30398797)
86. Simon WE, Albrecht M, Trams G, Dietel M, Holzel F. In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J Natl Cancer Inst 1984;73:313-21. (Pubitemid 14055210)
87. Moran TJ, Gray S, Mikosz CA, Conzen SD. The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res 2000;60:867-72. (Pubitemid 30129517)
88. Antonova L, Mueller CR. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Genes Chromosomes Cancer 2008;47:341-52. (Pubitemid 351323764)
89. Herr I, Ucur E, Herzer KEA. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res 2003; 63:3112-20. (Pubitemid 36735861)
90. Wu W, Chaudhuri S, Brickley DR. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 2004;64:1757-64. (Pubitemid 38428699)
91. Pang D, Kocherginsky M, Krausz T, Kim SY, Conzen SD. Dexamethasone decreases xenograft response to paclitaxel through inhibition of tumor cell apoptosis. Cancer Biol Ther 2006;5:933-40.
92. Williams JB, Pang D, Delgado B, Kocherginsky M, Tretiakova M, Krausz T, Pan D, He J, McClintock MK, Conzen SD. A model of geneenvironment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation. Cancer Prev Res (Phila) 2009;2:850-61.
93. Elenkov IJ. Glucocorticoids and the TH1/TH2 balance. Ann N YAcad Sci 2004;1024:138-46. (Pubitemid 38879598)
94. Holbrook N, Cox W, Horner H. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res 1983;43:4019-25. (Pubitemid 13041022)
95. Zhou J, Olsen S, Moldovan J, Fu X, Sarkar FH, Moudgil VK, Callewaert DM. Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line. Cell Immunol 1997;178:108-16. (Pubitemid 27397593)
96. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45. (Pubitemid 32173595)
97. Hagemann T, Balkwill F, Lawrence T. Inflammation and cancer: a doubleedged sword. Cancer Cell 2007;12:300-1.
98. Maier S, Watkins L. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107. (Pubitemid 128459559)
99. Capuron L, Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 2003;17:S119-24. (Pubitemid 36298524)
100. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31. (Pubitemid 43083561)
101. Pyter LM, Pineros V, Galang JA, McClintock MK, Prendergast BJ. Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. Proc Natl Acad Sci USA 2009;106:9069-74.
102. Lamkin DM, Lutgendorf SK, Lubaroff DM, Sood AK, Beltz TG, Johnson AK. Cancer induces inflammation and depressive-like behavior in the mouse: modulation by social housing. Brain Behav Immun 2011;25:555-64.
103. Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002;64: 604-11. (Pubitemid 34791163)
104. Collado-Hidalgo A, Bower ME, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006;12:2759-66.
105. Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005;30:92-100. (Pubitemid 39195048)
106. Weinrib A, Sephton SE, DeGeest K, Penedo F, Bender D, Zimmerman B, Kirschbaum C, Sood AK, Lubaroff DM, Lutgendorf SK. Diurnal cortisol dysregulation: links with depression and functional disability in women with ovarian cancer. Cancer 2010;116:4410-9.
107. Lutgendorf SK, Weinrib AZ, Penedo F, Russell D, DeGeest K, Costanzo ES, Henderson PJ, Sephton SE, Rohleder N, Lucci JA 3rd, Cole S, Sood AK, Lubaroff DM. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol 2008;26:4820-7.
108. Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252-7. (Pubitemid 32717699)
109. Jehn CF, Kuehnhardt D, Bartholomae A, Pfeiffer S, Krebs M, Regierer AC, Schmid P, Possinger K, Flath BC. Biomarkers of depression in cancer patients. Cancer 2006;107:2723-9. (Pubitemid 44845629)